ITRM
NASDAQ · Pharmaceuticals
Iterum Therapeutics Plc
$0.17
0.00 (-1.35%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+14,214.7% upside
Low Target
$15.49
Average Target
$24.02
High Target
$28.73
Current Price
$0.17
Current
$0.17
$0.17
Target
$24.02
$24.02
$15.49
$24.02 avg
$28.73
Scenario Analysis
Bear Case
$15.49
9,131.2%
Low target
Base Case
$24.02
+14,214.7%
Avg target
Bull Case
$28.73
+17,021.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$1.50
-88.8% from high
52-Week Low
$0.14
+23.7% from low
Target vs 52W High
$24.02
+1,501.3% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |